Eric Crombez
CIK 1653052 · EVP and Chief Medical Officer · last filed 2026-05-15
Eric Crombez is an EVP and Chief Medical Officer who has filed 21 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for ABEO, was dated May 15, 2026. Across all open-market trades the lifetime net is −$922.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.26M
3
21
-$922.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABEO | Director | 37,313 | $7.45 | $278.0K | -$260.2K | 6 | 2026-05-15 |
| RARE | EVP and Chief Medical Officer | 111,189 | $26.80 | $2.98M | -$662.6K | 10 | 2026-05-06 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | Chief Medical Officer | — | — | — | $0 | 3 | 2017-11-07 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-15 | ABEO | Notice (144) | −26,143 | -$144.6K | EDGAR |
| 2026-05-15 | ABEO | Sell (S) | −26,143 | -$144.6K | EDGAR |
| 2026-05-06 | RARE | Sell (S) | −344 | -$8.6K | EDGAR |
| 2026-04-20 | RARE | Grant (A) | +34,674 | $0 | EDGAR |
| 2026-03-03 | RARE | Mixed | +4,614 | -$160.3K | EDGAR |
| 2026-02-02 | ABEO | Notice (144) | −16,284 | -$82.9K | EDGAR |
| 2026-02-02 | ABEO | Sell (S) | −16,284 | -$82.9K | EDGAR |
| 2026-01-27 | ABEO | Grant (A) | +37,313 | $0 | EDGAR |
| 2025-08-15 | ABEO | Sell (S) | −4,718 | -$32.7K | EDGAR |
| 2025-05-05 | RARE | Sell (S) | −762 | -$28.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.